Key points
- AI scribes listen to consultations and generate clinical notes automatically — potentially saving <strong>30–60 minutes per day</strong>.
- The market has matured: key differentiators are now <strong>EHR integration, governance compliance (DTAC/MHRA), and note quality</strong> — not just transcription accuracy.
- No scribe is 'set and forget' — <strong>every AI-generated note must be reviewed and approved</strong> by the clinician.
Heidi Health (+ Heidi Evidence)
Tortus AI
Accurx (AI Scribe feature)
Nabla
Abridge
How to choose
Governance is not optional
The 'review every note' rule
Save your place and choose what comes next
Work through this guide (6 steps)
Use the actions from this article to track what you have worked through.
Sign in using the reading controls above to save your steps.
Heidi is one of the most widely used AI scribes in UK primary care. It transcribes consultations, generates SOAP-style or free-text notes, and integrates with EMIS and SystmOne. The 'Evidence' add-on provides clinical decision support by surfacing relevant guidelines during or after consultations. Strengths: mature UK market presence, EMIS/SystmOne integration, active NHS adoption. Considerations: subscription cost, note quality varies by consultation style — best for structured primary care consultations.
Return to this sectionTortus is a UK-developed AI scribe with strong NHS governance credentials, including DTAC compliance. It has been piloted in several NHS trusts and generates notes that integrate with existing EHR systems. Strengths: NHS-focused governance, growing evidence base (including HSJ-reported efficiency studies), designed for UK clinical workflows. Considerations: newer product — check current integration depth for your specific EHR.
Return to this sectionAccurx is primarily known as a patient communication platform widely used in UK general practice. It has added an AI scribe feature that integrates with its existing messaging and workflow tools. Strengths: if you already use Accurx for patient comms, the scribe is a natural extension — no new platform to learn. Considerations: the scribe is a feature within a broader platform, not a standalone product.
Return to this sectionNabla is an international AI scribe with a strong European presence. It supports multiple EHR systems and consultation styles. Strengths: multilingual support, clean interface, supports both primary care and hospital consultations. Considerations: UK-specific governance and EHR integration depth should be verified for your setting.
Return to this sectionAbridge is a US-based AI scribe with significant traction in the American market, including partnerships with major health systems. Strengths: deep US EHR integration (Epic), strong AI models, patient-facing features (patients can receive visit summaries). Considerations: UK adoption is limited — primarily relevant for US-based clinicians or those considering international tools.
Return to this sectionDecision criteria: (1) Does it integrate with your EHR (EMIS, SystmOne, Epic)? (2) Does it meet NHS governance requirements (DTAC, DCB0129/0160, DSPT) if you are in an NHS setting? (3) What is the cost per clinician per month? (4) What note formats does it support (SOAP, free-text, structured templates)? (5) How good is the note quality for your consultation style (short GP consultations vs longer specialist encounters)? Trial before you commit — most products offer free trials or pilot periods.
Return to this section
Digital tools · Article 26 of 28